397 related articles for article (PubMed ID: 28252200)
1. Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD).
Gadaleta RM; Garcia-Irigoyen O; Moschetta A
Curr Protoc Mouse Biol; 2017 Mar; 7(1):13-28. PubMed ID: 28252200
[TBL] [Abstract][Full Text] [Related]
2. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
3. Chemically induced mouse models of colitis.
Waldner MJ; Neurath MF
Curr Protoc Pharmacol; 2009 Sep; Chapter 5():Unit 5.55. PubMed ID: 22294401
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two models of inflammatory bowel disease in rats.
Catana CS; Magdas C; Tabaran FA; Crăciun EC; Deak G; Magdaş VA; Cozma V; Gherman CM; Berindan-Neagoe I; Dumitraşcu DL
Adv Clin Exp Med; 2018 May; 27(5):599-607. PubMed ID: 29616750
[TBL] [Abstract][Full Text] [Related]
5. Methods of Inducing Inflammatory Bowel Disease in Mice.
Bang B; Lichtenberger LM
Curr Protoc Pharmacol; 2016 Mar; 72():5.58.1-5.58.42. PubMed ID: 26995548
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease.
Katsandegwaza B; Horsnell W; Smith K
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012618
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease.
te Velde AA; de Kort F; Sterrenburg E; Pronk I; ten Kate FJ; Hommes DW; van Deventer SJ
Inflamm Bowel Dis; 2007 Mar; 13(3):325-30. PubMed ID: 17206675
[TBL] [Abstract][Full Text] [Related]
8. Chemically induced mouse models of intestinal inflammation.
Wirtz S; Neufert C; Weigmann B; Neurath MF
Nat Protoc; 2007; 2(3):541-6. PubMed ID: 17406617
[TBL] [Abstract][Full Text] [Related]
9. Chronic Model of Inflammatory Bowel Disease in IL-10
Wang H; Vilches-Moure JG; Cherkaoui S; Tardy I; Alleaume C; Bettinger T; Lutz A; Paulmurugan R
Theranostics; 2019; 9(21):6031-6046. PubMed ID: 31534535
[No Abstract] [Full Text] [Related]
10. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis.
Eichele DD; Kharbanda KK
World J Gastroenterol; 2017 Sep; 23(33):6016-6029. PubMed ID: 28970718
[TBL] [Abstract][Full Text] [Related]
11. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
[TBL] [Abstract][Full Text] [Related]
12. Murine Model for Colitis-Associated Cancer of the Colon.
Snider AJ; Bialkowska AB; Ghaleb AM; Yang VW; Obeid LM; Hannun YA
Methods Mol Biol; 2016; 1438():245-54. PubMed ID: 27150094
[TBL] [Abstract][Full Text] [Related]
13. Investigation of pulmonary involvement in inflammatory bowel disease in an experimental model of colitis.
Aydin B; Songur Y; Songur N; Aksu O; Senol A; Ciris IM; Sutcu R
Korean J Intern Med; 2016 Sep; 31(5):853-9. PubMed ID: 27539446
[TBL] [Abstract][Full Text] [Related]
14. Dextran sulfate sodium (DSS)-induced colitis in mice.
Chassaing B; Aitken JD; Malleshappa M; Vijay-Kumar M
Curr Protoc Immunol; 2014 Feb; 104():15.25.1-15.25.14. PubMed ID: 24510619
[TBL] [Abstract][Full Text] [Related]
15. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
16. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
[TBL] [Abstract][Full Text] [Related]
17. High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.
Holgersen K; Kutlu B; Fox B; Serikawa K; Lord J; Hansen AK; Holm TL
J Crohns Colitis; 2015 Jun; 9(6):492-506. PubMed ID: 25795566
[TBL] [Abstract][Full Text] [Related]
18. Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors.
Bauer C; Duewell P; Lehr HA; Endres S; Schnurr M
Dig Dis; 2012; 30 Suppl 1():82-90. PubMed ID: 23075874
[TBL] [Abstract][Full Text] [Related]
19. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
[TBL] [Abstract][Full Text] [Related]
20. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
